Moderna: Stop CMV Silence Campaign

We launched the "Stop CMV Silence" campaign to raise awareness and increase participation in a clinical trial for Moderna's mRNA-1647 vaccine, which could potentially combat the leading infectious cause of birth defects in the US - Cytomegalovirus (CMV).

BRANDING

WEB

SOCIAL

UX/UI

Site layout

Social, digital, print and email materials

Customized iconography

  • Concept: "Stop CMV Silence" designed to evoke urgency and empowerment.

    Elements: Impactful branding and cohesive visual identity aimed to break the silence surrounding CMV and mobilize community action.

    Messaging: Emphasized collective responsibility and the transformative potential of Moderna's vaccine trial in maternal and child health.

  • Website Development: Created a dynamic and user-friendly website as a centralized hub for CMV education and trial information.

    UX/UI Enhancements: Ensured seamless navigation and optimized user experiences to facilitate efficient trial enrollment and participant engagement.

    Social Media Strategy: Utilized social media platforms to amplify reach, engage the target audience with interactive content, and build a community.

  • The "Stop CMV Silence" campaign achieved notable success in driving CMV awareness and trial participation. Metrics such as website traffic, social media engagement, and trial enrollment rates surpassed expectations, indicating strong resonance with the target demographic. The campaign's impact extended beyond numerical metrics, fostering a sense of community and empowerment among participants and stakeholders.

    MM+M AWARDS Silver, Use of Clinical Trial Marketing 2022

Other Pharma Projects: